Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502106186

ACROBiosystems Protein, Human Latent GDF-8, His Tag, 50 μg

Catalog No. 502106186
Encompass_Preferred

Growth differentiation factor 8 (GDF8), or myostatin, is a member of the transforming growth factor-β superfamily that acts as a negative regulator of skeletal muscle growth and differentiation. This human latent GDF-8 protein is expressed from human 293 cells (HEK293) and contains amino acids Asn 24 to Ser 375 with an N-terminal His tag. The protein is designed as a dimer and is verified by mass spectrometry and SEC-MALS.

  • Greater than 90% purity by SDS-PAGE and >95% purity by SEC-MALS.
  • Low endotoxin levels, less than 0.01 EU per μg.
  • Lyophilized from a 0.22 μm filtered solution of PBS, 0.2 M Arginine, pH 7.4 with trehalose.
  • Achieves 98.7% sequence coverage in LC-MS/MS peptide mapping.
  • Validated by binding activity assays for Activin RIIB, Follistatin, and Apitegromab.

Catalog No. 50-210-6186 Supplier ACROBiosystems Supplier No. GD8H524350UG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Growth differentiation factor 8 (GDF8), or myostatin, is a member of the transforming growth factor-β superfamily that acts as a negative regulator of skeletal muscle growth and differentiation. This human latent GDF-8 protein is expressed from human 293 cells (HEK293) and contains amino acids Asn 24 to Ser 375 with an N-terminal His tag. The protein is designed as a dimer and is verified by mass spectrometry and SEC-MALS.

  • Greater than 90% purity by SDS-PAGE and >95% purity by SEC-MALS.
  • Low endotoxin levels, less than 0.01 EU per μg.
  • Lyophilized from a 0.22 μm filtered solution of PBS, 0.2 M Arginine, pH 7.4 with trehalose.
  • Achieves 98.7% sequence coverage in LC-MS/MS peptide mapping.
  • Validated by binding activity assays for Activin RIIB, Follistatin, and Apitegromab.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.